Mallinckrodt Pays $35M to Settle Opioid Drug Probe

The Mallinckrodt deal marked a record settlement resulting from a drug manufacturer not notifying the U.S. DEA of suspicious drug orders.

July 12, 2017

Mallinckrodt Plc, which makes generic opioid painkiller oxycodone, agreed to pay $35 million to settle allegations that it did not report suspicious drug orders, according to a Reuters report. However, Mallinckrodt did not admit any wrongdoing.

The deal was said to be a record settlement resulting from a drug manufacturer not notifying the U.S. Drug Enforcement Administration of suspicious drug orders such as oxycodone, the Justice Department said.

U.S. Attorney General Jeff Sessions said the settlement will send a message to other drugmakers that the Justice Department will hold them accountable for their actions, the story said.

Read the full article